Researchers at University of California San Diego have discovered how healthy stem cells are transformed into cancer stem cells in the earliest stages of the disease. The study was published in Nature Communications.
Researchers at University of California San Diego School of Medicine have discovered that an enzyme called MICAL2 promotes tumor growth and spread in pancreatic ductal adenocarcinomas, the most common form of pancreatic cancer.
Diane Simeone, director of Moores Cancer Center at UC San Diego Health, has expanded her leadership team.
Alligator Bioscience has announced the initiation of a phase I clinical study (NCT06205849) to evaluate the safety and efficacy of mitazalimab (CD40 mAb agonist) injected intratumorally at the time of surgical irreversible electroporation (IRE) in patients with locally advanced pancreatic cancer.
Diane M. Simeone will become director of Moores Cancer Center at UC San Diego Health effective April 1.
Seanne Falconer was named administrative director at Tulane Cancer Center at Tulane University School of Medicine.
Elaine A. Muchmore, of University of California, San Diego, will receive the 2023 Exemplary Service Award from the American Society of Hematology for her exceptional service and dedication to the Society and the field of hematology.
Researchers at University of California San Diego have discovered a process in which liver cells share molecules via vesicle exchange in order to multiply under conditions that would ordinarily suppress cell proliferation. They also found evidence that this process occurs in various types of cancer cells, paving the way for a new approach to tackling treatment resistance in cancer.
Leslie A. Crews, assistant professor of medicine in the Division of Regenerative Medicine at UC San Diego, was named co-leader of the MCC Hematologic Malignancies Program. Crews will join current co-leader, Thomas Kipps, professor of medicine and Evelyn and Edwin Tasch Chair in Cancer Research.
Jason Sicklick was named co-leader of the Structural and Functional Genomics Research Program at the UC San Diego Moores Cancer Center. Sicklick will join current co-leader, Jill Mesirov.
